Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: Italy Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20053
20091
20102
20131
20162
20172
20181
20193
20202
20213
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Active, not recruiting3
Recruiting2
Unknown status2
Withdrawn1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Fred Hutchinson Cancer Center5
Novartis Pharmaceuticals4
Astex Pharmaceuticals, Inc.2
Taiho Oncology, Inc.2
Traws Pharma, Inc.2
AbbVie1
Cogent Biosciences, Inc.1
Fondazione Italiana Sindromi Mielodisplastiche-ETS1
Hemavant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic31
Leukemia, Myeloid, Acute20
Myelodysplastic Syndromes20
Leukemia, Lymphocytic, Chronic, B-Cell10
Myeloproliferative Disorders10
Hodgkin Disease9
Lymphoma, B-Cell, Marginal Zone9
Lymphoma, Large B-Cell, Diffuse9
Lymphoma, Mantle-Cell9
Lymphoma, Non-Hodgkin9

Trials

Showing 51 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.